CTSO 8-K: SEC filing
CytoSorbents Corporation
Filed with the SEC on · accession 0000929638-26-004267
CTSO filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
CytoSorbents Corporation issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.
Key details
✦ Ask GOAX AI about this filing — what it means for CTSO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CTSO?
Click hereFrequently asked questions
What did CTSO file with the SEC on Nov 12, 2026?
CTSO filed a 8-K (SEC filing). CytoSorbents Corporation issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished as Exhibit 99.1 to this Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other CTSO SEC filings
Get alerts when CTSO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days